Berger Financial Group Inc Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Berger Financial Group Inc has reduced its holdings in Intuitive Surgical, Inc. by 30.2%, now owning 4,163 shares valued at approximately $2.06 million.
• Intuitive Surgical reported earnings of $2.19 per share and revenues of $2.44 billion for the last quarter, exceeding analyst expectations.
• Institutional investors hold a substantial 83.64% of Intuitive Surgical's shares, with several firms increasing their stakes recently.

Berger Financial Group Inc lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 30.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,163 shares of the medical equipment provider's stock after selling 1,803 shares during the period. Berger Financial Group Inc's holdings in Intuitive Surgical were worth $2,062,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock worth $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Northern Trust Corp raised its stake in shares of Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after purchasing an additional 494,496 shares during the last quarter. Capital Research Global Investors boosted its position in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares during the last quarter. GAMMA Investing LLC increased its holdings in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after buying an additional 3,022,979 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Intuitive Surgical by 12.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider's stock valued at $1,475,566,000 after acquiring an additional 319,694 shares during the period. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price objective for the company from $515.00 to $440.00 in a report on Monday, June 9th. Royal Bank Of Canada increased their price objective on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a report on Wednesday, July 23rd. Piper Sandler reissued an "overweight" rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, UBS Group increased their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gary S. Guthart sold 2,800 shares of the business's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares in the company, valued at $9,171,844.80. This trade represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,881 shares of company stock valued at $7,920,634 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $6.34 on Tuesday, hitting $478.19. The stock had a trading volume of 1,529,402 shares, compared to its average volume of 2,211,435. The business's fifty day moving average price is $514.89 and its 200 day moving average price is $527.45. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $171.42 billion, a price-to-earnings ratio of 66.69, a price-to-earnings-growth ratio of 4.95 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the previous year, the company earned $1.78 earnings per share. The business's revenue for the quarter was up 21.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.